In the US, patients diagnosed with noninfectious uveitis (NIU) are higher in number than infectious uveitis (IU). In 2022, ...

In February 2025, BioRestorative Therapies announced that the FDA cleared its Investigational New Drug (IND) application for ...

Aim To evaluate the long-term outcomes of intravitreal triamcinolone acetonide (TA) administration after posterior vitreous detachment (PVD) during pars plana vitrectomy (PPV) for patients with ...

The top cataract posters at ASCRS reviewed pre- and postoperative medical eye drops, IOL technologies, and legislative ...

Background: This study was designed to compare the efficacy and complications between 3 different dosages of triamcinolone acetonide for the treatment of trigger finger.. Methods: Ninety-three ...

Partner: Aura Biosciences Title: Bel-sar - a New Treatment Paradigm in Choroidal Melanoma: Update on the Global Phase 3 CoMpass Trial Presented by: Jennifer Lim, MD, Professor of Ophthalmology, ...

Pacira BioSciences, Inc. (NASDAQ: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the debut of a powerful new ...

Am J Health Syst Pharm. 2005;62(5):485-491. A stock solution of triamcinolone acetonide standard m was prepared in ethanol and diluted to yield concentrations of 2, 4, 8, 12, and 16 µg/mL ...

Find Injective (INJ) price predictions for 2025, 2026 and 2030. Discover key investment factors, risks and analyst forecasts for this leading DeFi blockchain.

Merck gets lift from U.S. patent office in battle over injectable form of Keytruda Dispute with Halozyme Therapeutics could affect plans to extend its franchise product Manage alerts for this article ...